Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles

References

• Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 1992;7:49–66
   PubMed Web of Science ®Google Scholar
• Papanikolaou EG, Pados G, Grimbizis G, et al. GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod 2012;27:1822–8
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60000 cycles. Hum Reprod Update 2013;19:433–57
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Papanikolaou E, et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13:343–55
   PubMed Web of Science ®Google Scholar
• Kyrou D, Al-Azemi M, Papanikolaou EG, et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol 2012;162:165–8
   PubMed Web of Science ®Google Scholar
• Yding Andersen C, Bungum L, Nyboe Andersen A, Humaidan P. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online 2011;23:187–95
   PubMed Web of Science ®Google Scholar
• Al-Azemi M, Kyrou D, Kolibianakis EM, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381–8
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, Olivennes F, et al. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril 1997;68:799–805
   PubMed Web of Science ®Google Scholar
• Elnashar AM. Progesterone rise on the day of hCG administration (premature luteinization) in IVF: an overdue update. J Assist Reprod Genet 2010;27:149–55
   PubMed Web of Science ®Google Scholar
• Chetkowski RJ, Kiltz RJ, Salyer WR. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril 1997;68:292–7
   PubMed Web of Science ®Google Scholar
• Melo MA, Meseguer M, Garrido N, et al. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod 2006;21:1503–7
   PubMed Web of Science ®Google Scholar
• Saadat P, Boostanfar R, Slater CC, et al. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 2004;82:167–71
   PubMed Web of Science ®Google Scholar
• Labarta E, Martinez-Conejero JA, Alama P, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011;26:1813–25
   PubMed Web of Science ®Google Scholar
• Van Vaerenbergh I, Fatemi HM, Bourgain C. Premature progesterone rise and gene expression. Hum Reprod 2011;26:2913
   PubMed Web of Science ®Google Scholar
• Baczkowski T, Kurzawa R, Glabowski W. Methods of embryo scoring in in vitro fertilization. Reprod Biol 2004;4:5–22
   PubMedGoogle Scholar
• Fisch JD, Rodriguez H, Ross R, et al. The Graduated Embryo Score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos. Hum Reprod 2001;16:1970–5
   PubMed Web of Science ®Google Scholar
• Brown JB. Pituitary control of ovarian function-concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol 1978;18:46–54
   PubMed Web of Science ®Google Scholar
• Sonigo C, Dray G, Roche C, et al. Impact of high serum progesterone during the late follicular phase on IVF outcome. Reprod Biomed Online 2014;29:177–86
   PubMed Web of Science ®Google Scholar
• Hofmann GE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675–9
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, Olivennes F, et al. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178–83
   PubMed Web of Science ®Google Scholar
• Huang CC, Lien YR, Chen HF, et al. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles. Hum Reprod 2012;27:2036–45
   PubMed Web of Science ®Google Scholar
• Kyrou D, Kolibianakis EM, Fatemi HM, et al. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2011;96:884–8
   PubMed Web of Science ®Google Scholar
• Papanikolaou EG, Kolibianakis EM, Pozzobon C, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril 2009;91:949–52
   PubMed Web of Science ®Google Scholar
• Elgindy EA, Abou-Setta AM, Mostafa MI. Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial. Reprod Biomed Online 2011;23:789–98
   PubMed Web of Science ®Google Scholar
• Ochsenkühn R, Arzberger A, von Schönfeldt V, et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril 2012;98:347–54
   PubMed Web of Science ®Google Scholar
• Corti L, Papaleo E, Pagliardini L, et al. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law. Eur J Obstet Gynecol Reprod Biol 2013;171:73–7
   PubMed Web of Science ®Google Scholar